Evaluation of Renvela in Patients With Chronic Kidney Disease Not On Dialysis And Hyperphosphatemia In China
Condition: Hyperphosphatemia Interventions: Drug: Placebo; Drug: Sevelamer Carbonate (GZ419831) Sponsor: Sanofi Not yet recruiting - verified December 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials